1793 related articles for article (PubMed ID: 32430279)
1. Gut microbiota and Covid-19- possible link and implications.
Dhar D; Mohanty A
Virus Res; 2020 Aug; 285():198018. PubMed ID: 32430279
[TBL] [Abstract][Full Text] [Related]
2. Immunological co-ordination between gut and lungs in SARS-CoV-2 infection.
Ahlawat S; Asha ; Sharma KK
Virus Res; 2020 Sep; 286():198103. PubMed ID: 32717345
[TBL] [Abstract][Full Text] [Related]
3. Probiotics in Treatment of Viral Respiratory Infections and Neuroinflammatory Disorders.
Shahbazi R; Yasavoli-Sharahi H; Alsadi N; Ismail N; Matar C
Molecules; 2020 Oct; 25(21):. PubMed ID: 33105830
[TBL] [Abstract][Full Text] [Related]
4. Potential contribution of beneficial microbes to face the COVID-19 pandemic.
Antunes AEC; Vinderola G; Xavier-Santos D; Sivieri K
Food Res Int; 2020 Oct; 136():109577. PubMed ID: 32846611
[TBL] [Abstract][Full Text] [Related]
5. Alterations in Gut Microbiota of Patients With COVID-19 During Time of Hospitalization.
Zuo T; Zhang F; Lui GCY; Yeoh YK; Li AYL; Zhan H; Wan Y; Chung ACK; Cheung CP; Chen N; Lai CKC; Chen Z; Tso EYK; Fung KSC; Chan V; Ling L; Joynt G; Hui DSC; Chan FKL; Chan PKS; Ng SC
Gastroenterology; 2020 Sep; 159(3):944-955.e8. PubMed ID: 32442562
[TBL] [Abstract][Full Text] [Related]
6. COVID-19 - gastrointestinal and gut microbiota-related aspects.
Kaźmierczak-Siedlecka K; Vitale E; Makarewicz W
Eur Rev Med Pharmacol Sci; 2020 Oct; 24(20):10853-10859. PubMed ID: 33155247
[TBL] [Abstract][Full Text] [Related]
7. Impact of Microbiota: A Paradigm for Evolving Herd Immunity against Viral Diseases.
Shelly A; Gupta P; Ahuja R; Srichandan S; Meena J; Majumdar T
Viruses; 2020 Oct; 12(10):. PubMed ID: 33050511
[TBL] [Abstract][Full Text] [Related]
8. Music of microbiota against SARS CoV-2.
Belojevic G; Prasher D
Noise Health; 2019; 21(100):97. PubMed ID: 32655062
[No Abstract] [Full Text] [Related]
9. ACE2 imbalance as a key player for the poor outcomes in COVID-19 patients with age-related comorbidities - Role of gut microbiota dysbiosis.
Viana SD; Nunes S; Reis F
Ageing Res Rev; 2020 Sep; 62():101123. PubMed ID: 32683039
[TBL] [Abstract][Full Text] [Related]
10. Role of probiotics to combat viral infections with emphasis on COVID-19.
Sundararaman A; Ray M; Ravindra PV; Halami PM
Appl Microbiol Biotechnol; 2020 Oct; 104(19):8089-8104. PubMed ID: 32813065
[TBL] [Abstract][Full Text] [Related]
11. Premises among SARS-CoV-2, dysbiosis and diarrhea: Walking through the ACE2/mTOR/autophagy route.
de Oliveira AP; Lopes ALF; Pacheco G; de Sá Guimarães Nolêto IR; Nicolau LAD; Medeiros JVR
Med Hypotheses; 2020 Nov; 144():110243. PubMed ID: 33254549
[TBL] [Abstract][Full Text] [Related]
12. COVID-19: Is there a role for immunonutrition in obese patient?
Di Renzo L; Gualtieri P; Pivari F; Soldati L; Attinà A; Leggeri C; Cinelli G; Tarsitano MG; Caparello G; Carrano E; Merra G; Pujia AM; Danieli R; De Lorenzo A
J Transl Med; 2020 Nov; 18(1):415. PubMed ID: 33160363
[TBL] [Abstract][Full Text] [Related]
13. Coronavirus Disease (COVID-19) Caused by (SARS-CoV-2) Infections: A Real Challenge for Human Gut Microbiota.
Vodnar DC; Mitrea L; Teleky BE; Szabo K; Călinoiu LF; Nemeş SA; Martău GA
Front Cell Infect Microbiol; 2020; 10():575559. PubMed ID: 33363049
[TBL] [Abstract][Full Text] [Related]
14. Probiotics in Medicine: A Long Debate.
Stavropoulou E; Bezirtzoglou E
Front Immunol; 2020; 11():2192. PubMed ID: 33072084
[TBL] [Abstract][Full Text] [Related]
15. Microbiota Modulation of the Gut-Lung Axis in COVID-19.
de Oliveira GLV; Oliveira CNS; Pinzan CF; de Salis LVV; Cardoso CRB
Front Immunol; 2021; 12():635471. PubMed ID: 33717181
[TBL] [Abstract][Full Text] [Related]
16. Immunologic aspects of characteristics, diagnosis, and treatment of coronavirus disease 2019 (COVID-19).
Chang FY; Chen HC; Chen PJ; Ho MS; Hsieh SL; Lin JC; Liu FT; Sytwu HK
J Biomed Sci; 2020 Jun; 27(1):72. PubMed ID: 32498686
[TBL] [Abstract][Full Text] [Related]
17. Potential Causes and Consequences of Gastrointestinal Disorders during a SARS-CoV-2 Infection.
Trottein F; Sokol H
Cell Rep; 2020 Jul; 32(3):107915. PubMed ID: 32649864
[TBL] [Abstract][Full Text] [Related]
18. SARS-CoV-2 infection protects against rechallenge in rhesus macaques.
Chandrashekar A; Liu J; Martinot AJ; McMahan K; Mercado NB; Peter L; Tostanoski LH; Yu J; Maliga Z; Nekorchuk M; Busman-Sahay K; Terry M; Wrijil LM; Ducat S; Martinez DR; Atyeo C; Fischinger S; Burke JS; Slein MD; Pessaint L; Van Ry A; Greenhouse J; Taylor T; Blade K; Cook A; Finneyfrock B; Brown R; Teow E; Velasco J; Zahn R; Wegmann F; Abbink P; Bondzie EA; Dagotto G; Gebre MS; He X; Jacob-Dolan C; Kordana N; Li Z; Lifton MA; Mahrokhian SH; Maxfield LF; Nityanandam R; Nkolola JP; Schmidt AG; Miller AD; Baric RS; Alter G; Sorger PK; Estes JD; Andersen H; Lewis MG; Barouch DH
Science; 2020 Aug; 369(6505):812-817. PubMed ID: 32434946
[TBL] [Abstract][Full Text] [Related]
19. Considerations for Gut Microbiota and Probiotics in Patients with Diabetes Amidst the Covid-19 Pandemic: A Narrative Review.
Barengolts E; Smith ED
Endocr Pract; 2020 Oct; 26(10):1186-1195. PubMed ID: 33471720
[TBL] [Abstract][Full Text] [Related]
20. Role of neutrophil chemoattractant CXCL5 in SARS-CoV-2 infection-induced lung inflammatory innate immune response in an
Liang Y; Li H; Li J; Yang ZN; Li JL; Zheng HW; Chen YL; Shi HJ; Guo L; Liu LD
Zool Res; 2020 Nov; 41(6):621-631. PubMed ID: 33045777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
